Hengli Petrochemical (600346.SH): Restructuring matters approved through anti-monopoly review.
Connect global capital markets.
"Hengli Petrochemical (600346.SH) Announcement: Recently, the company received a Notice of Decision from the State Administration for Market Regulation, stating that the further review of the concentration of business operators in the case of Hengli Petrochemical's acquisition of Dalian Thermal Power Co., Ltd.'s equity will not be implemented. The specific content is as follows: "According to Article 30 of the Anti-Monopoly Law of the People's Republic of China, after preliminary review, it is now decided that no further review will be conducted on the Hengli Petrochemical Co., Ltd.'s acquisition of Dalian Thermal Power Co., Ltd.'s equity. Your company can proceed with the concentration from now on. The case involves matters other than the antitrust review of business concentration, which shall be handled in accordance with relevant laws."
Related Articles

Shanghai Fosun Pharmaceutical (02196) released its performance for the first three quarters, with a net profit attributable to shareholders of 2.523 billion yuan, an increase of 25.5% year-on-year.
.png)
ACESO LIFE SCI (00474): Fully repay the outstanding loan from a commercial bank in Hong Kong.

BOC Aviation (02588): Zhao Chengwen appointed as Executive Director and Chairman.
Shanghai Fosun Pharmaceutical (02196) released its performance for the first three quarters, with a net profit attributable to shareholders of 2.523 billion yuan, an increase of 25.5% year-on-year.

ACESO LIFE SCI (00474): Fully repay the outstanding loan from a commercial bank in Hong Kong.
.png)
BOC Aviation (02588): Zhao Chengwen appointed as Executive Director and Chairman.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025


